Online Exclusives

Online Exclusives

CDC Reports That Brain Cancer Surpasses Leukemia as Leading Cause of Cancer Mortality in...

A report from the National Center for Health Statistics – part of the Centers for Disease Control and Prevention (CDC) – found that nearly...

World Health Organization Urges Necessity of the Affordable Care Act

The World Health Organization (WHO) urged U.S. President-elect Donald Trump to expand the Affordable Care Act once he is in office. Agnes Soucat, the director...

Socioeconomic Factors May Impact Multiple Myeloma Survival

A study found that two specific socioeconomic factors – household income and education level – play an important role in long-term survival among patients...

Clinical Trial of Investigational Multiple Myeloma Drug BI-505 Placed on Hold

A phase II study evaluating the investigational agent BI-505 for patients with multiple myeloma (MM) was placed on full clinical hold by the U.S....

Manufacturer of Blinatumomab Seeks Expanded U.S. FDA Approval for Pediatric ALL

A supplemental biologics license application has been submitted to the U.S. Food and Drug Administration (FDA) to expand blinatumomab’s approval to include the treatment...

Europe’s CHMP Recommends Ixazomib for Multiple Myeloma

Europe’s Committee for Medicinal Products for Human Use (CHMP) recommended approval for ixazomib in combination with lenalidomide and dexamethasone for patients with multiple myeloma...

Conference Coverage: Updates on Idelalisib in CLL and FL: Superior PFS and Durable Responses

CHICAGO—Two posters presented at the 2015 ASCO Annual Meeting provided encouraging data for the use of the pi3k delta inhibitor idelalisib in the treatment...

European Commission Approves Lenalidomide for Relapsed/Refractory Mantle Cell Lymphoma

The European Commission approved lenalidomide for the treatment of adult patients with relapsed/refractory mantle cell lymphoma (MCL), following a recommendation earlier this year from...

National Institutes of Health Funds Study of Zika Virus Exposure in Olympic Athletes

The National Institutes of Health’s (NIH) Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) is funding a research initiative to...

FDA Grants Fast-Track Designation to Tazemetostat for DLBCL

The U.S. Food and Drug Administration granted fast-track designation to tazemetostat for patients with relapsed/refractory diffuse large B-cell lymphoma with EZH2-activating mutations. Tazemetostat is...
Advertisement

Current Issue

June 2021 Volume 7 Issue 7

This issue reviews the management and prevention of peripheral neuropathy, early successes of SCD screening programs in sub-Saharan Africa, and more.

Block title